Lopinavir/ritonavir single agent therapy as a universal combination antiretroviral therapy stopping strategy: results from the STOP 1 and STOP 2 studies | Zendy

Stephen Taylor | Zendy; A. Jayasuriya | Zendy; Martin Fisher | Zendy; Sris Allan | Zendy; Edmund Wilkins | Zendy; G Gilleran | Zendy; Lynn M. Heald | Zendy; Sarah Fidler | Zendy; Andrew Owen | Zendy; David Back | Zendy; Erasmus Smit | Zendy

Open Access

Lopinavir/ritonavir single agent therapy as a universal combination antiretroviral therapy stopping strategy: results from the STOP 1 and STOP 2 studies

Author(s) -

Stephen Taylor,

A. Jayasuriya,

Martin Fisher,

Sris Allan,

Edmund Wilkins,

G Gilleran,

Lynn M. Heald,

Sarah Fidler,

Andrew Owen,

David Back,

Erasmus Smit

Publication year - 2011

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkr491

Subject(s) - lopinavir , lopinavir/ritonavir , antiretroviral therapy , ritonavir , medicine , cart , rescue therapy , human immunodeficiency virus (hiv) , virology , intensive care medicine , viral load , mechanical engineering , engineering

We designed two different studies to evaluate two different combination antiretroviral therapy (cART) stopping strategies namely a 'staggered stop' approach (STOP 1 study) and a 'protected stop' approach (STOP 2 study) to find the best 'universal stop' strategy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research